Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients

NCT05957887 is registered in ClinicalTrials.gov with Mohamed Nabil Elkholy as lead sponsor.

NCT NCT05957887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05957887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients
Lead sponsor
Mohamed Nabil Elkholy
Phase
Phase 3
Overall status
Unknown status
Start date
April 15, 2022
Completion date
April 15, 2025
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stemi